Abstract
We report two fatal cases of acute liver failure secondary to herpes simplex virus 1 infection in COVID-19 patients, following tocilizumab and corticosteroid therapy. Screening for and prompt recognition of herpes simplex virus 1 reactivation in these patients, undergoing immunomodulatory treatment, may have potentially relevant clinical consequences.
Cite
CITATION STYLE
Busani, S., Bedini, A., Biagioni, E., Serio, L., Tonelli, R., Meschiari, M., … Fregni Serpini, G. (2021). Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients following Immunomodulatory Therapies. Clinical Infectious Diseases, 73(1), E252–E255. https://doi.org/10.1093/cid/ciaa1246
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.